Accéder à l'en-tête Accéder au contenu principal Accéder au pied de page
Back
Publié le 17/03/2025 |

Female Success: A Plural Definition and a Path to Autonomy

At Laboratoire XO, we celebrated Women’s Rights Day by redefining success: unique to each woman, rooted in autonomy, and built on inclusivity.

On International Women’s Rights Day, Laboratoire XO hosted an inspiring roundtable on female success. Our CEO, Karine Pinon, shared her experience and emphasized a powerful message: intellectual and financial autonomy are essential for women to thrive, and success has no single definition—each woman should shape it according to her own aspirations.

Read more on LinkedIn
Featured

Discover laboratory news

LXO Group publishes its latest ESG report

LXO Group publishes its latest ESG report

LXO Group is proud to announce the publication of its latest ESG report. The report details the company’s efforts and achievements over the past year in terms of sustainability, ethics and social commitment. 04.09.24
LXO Group announces the acquisition of prescription drug Nimotop® from Bayer

LXO Group announces the acquisition of prescription drug Nimotop® from Bayer

Press Release, november 06th, 2023 – Laboratoire X.O (“LXO”), is pleased to announce the acquisition of prescription drug Nimodipine under the brand name Nimotop® from Bayer, for several markets across different regions. 06.11.23
LXO Group moves into a new phase of growth with the support of Stanley Capital

LXO Group moves into a new phase of growth with the support of Stanley Capital

Press Release, october 04th, 2022 – Stanley Capital Partners (SCP) has acquired a majority stake in French pharmaceutical group Laboratoire XO (Lab XO). Debt was provided by US giant Ares Management. 04.10.22
See all news